Skip to main content
. 2020 Sep 17;2020:1020843. doi: 10.1155/2020/1020843

Table 1.

Clinical specificity of SARS-CoV-2 IgM and SARS-CoV-2 IgG.

Number of samples SARS-CoV-2 IgM SARS-CoV-2 IgG
N P Clin Spe (%) 95% CI N P Clin Spe (%) 95% CI
Suspected group 9 9 0 100.00 (70.1%, 100.0%) 9 0 100.00 (70.1%, 100.0%)
Control group 101 100 1 99.01 (94.6%, 99.8%) 97 4 96.04 (90.3%, 98.4%)

N: negative; P: positive; Clin Sep: clinical specificity.